NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Food & Drug Law Weekly


Susan Hasty, Publisher
Table of Contents . . . August 22nd, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Food & Drug Law Weekly | Other Publications

Alzheimer Disease - Medivation Presents Positive New Data On Dimebons Long-term Efficacy and Novel Mechanism of Action At the International Conference On Alzheimers Disease

American Sociological Association - Toxic drugs, toxic system: Sociologist predicts drug disasters

California Tomato Farmers - Tomato Industry Leaders Testify on Legislation Based on California/Florida Model Programs

Cystic Fibrosis - Inspire Announces Peer-reviewed Publications Related To Denufosol for Cystic Fibrosis

Luna Innovations Incorporated - Luna Innovations Reports Second Quarter 2008 Financial Results

Merck & Co., Inc. - ISENTRESS raltegravir, Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell Counts Through 96 Weeks in Treatment-Naive HIV-Infected Patients When Taken With Other Anti

Micrus Endovascular Corporation - Micrus Endovascular Reports First Quarter Financial Results

U.S. Department of Justice - Statement by the Department of Justice on the Anthrax Investigation

Abiomed, Inc. - Abiomed Announces Impella 2.5 Capacity Expansion Plans in Ireland

Adolor Corporation - Adolor Corporation Reports Second Quarter 2008 Financial Results

Aeolus Pharmaceuticals, Inc. - Aeolus Pharmaceuticals Announces Third Quarter Fiscal Year 2008 Financial Results

Affymetrix Inc. - Affymetrix Microarray Platform Granted Clearance from FDA for Gene Expression Diagnostic Testing

Alkermes, Inc. - Alkermes Announces Approval of VIVITROL for the Treatment of Alcohol Dependence in Russia

Allergies - USPTO Issues Patent Embodying Methodologies for Abating a Broad Range of Allergens, Pathogens, Viruses, Bacteria, Odors and Volatile Organic Compounds.

Amyloid Polyneuropathy Epidemiology - Data from Kanazawa University provide new insights into amyloid polyneuropathy epidemiology

Antigenics Inc. - Antigenics Reports Second Quarter 2008 Financial Results

Arrhythmia - Urologists Should Recognize the Cardiac Safety of Prescribed Medications, Article Concludes

Artes Medical, Inc. - Artes Medical Initiates Market Launch and Commercial Sale of Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler

Banner Pharmacaps Inc. - Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules

BioSante Pharmaceuticals, Inc. - BioSante Pharmaceuticals Announces Reacquisition of Elestrin, FDA Approved for Treatment of Hot Flashes

Biotechnology Business - Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results

Breast Cancer Screening - New breast cancer screening study findings have been published by I. Carelli and colleagues

Breast Cancer Screening - New breast cancer screening study findings recently were published by I. Carelli and co-researchers

Cancer - Fda Clears the Pathwork® Tissue of Origin Test for Hard-to-identify Tumors

Cancer - FDA Remains Asleep at the Wheel on the Dangers of Sunscreens, Besides Other Cosmetics and Personal Care Products

Cancer - Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105

Centocor, Inc. - FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months

Central Nervous System Disease - FDA Accepts Streamlined Phase 3 Development Plan for Q8003IR gDual Opioidh Pain Therapy

ConforMIS, Inc. - ConforMIS, Inc. Launches First Patient-Specific, Bicompartmental Knee Resurfacing System on the Market

Cook Medical - Cook Medical Receives FDA Approval to Market Improved Zenith AAA Iliac Flex Legs and Z-Trak Introduction System

CSMG Technologies, Inc. - CSMG Technologies Announces U.S. FDA 510k Clearance for Live Tissue Connect's VAD System

Datatrak International, Inc. - DATATRAK International, Inc. Announces 2008 Second Quarter and First-Half Operating Results

Dengue Fever - New dengue fever study results from University of California described

Discectomy - Data on discectomy described by M. Leahy et al

Drug Development - Cadence Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Overview of Clinical Programs

Drug Development - SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results

Drug Development - SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation

Drug Safety - iGuard.org Reaches 500,000-Member Milestone 12 Months Early

Emergent BioSolutions Inc. - Emergent BioSolutions Reports Financial Results for Second Quarter 2008

Emergent BioSolutions Inc. - Emergent BioSolutions Submits Proposal in Response to HHS RFP for Development and Procurement of a Recombinant Protective Antigen Anthrax Vaccine

Enzyme Research - Data on enzyme research reported by M.J. Feito and co-researchers

Escherichia Coli - Research from University of Tokyo in Escherichia coli provides new insights

Escherichia Coli - Researchers at University of Oklahoma target Escherichia coli

Genetics & Genomics - Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease

Glioblastoma - SuperGen Granted Orphan Drug Designation for MP-470 in Glioblastoma Multiforme

GTC Biotherapeutics, Inc. - GTC Biotherapeutics Reports Second Quarter 2008 Financial Results

GTx, Inc. - GTx, Inc. Reports Second Quarter 2008 Financial Results

Hantavirus Therapy - Reports by N.D. Tischler and co-researchers describe recent advances in hantavirus therapy

Heart Failure - Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure

Heart Transplants - First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan

Hemorrhagic Fever - Research on hemorrhagic fever described by scientists at Institute of Endocrinology

Hemorrhagic Fever - Study results from M.A. Evika and colleagues in the area of hemorrhagic fever published

HepaLife Technologies, Inc. - HepaLife Achieves 20-Fold Increase in Cell Production for Bioartificial Liver While Reducing Labor 4-Fold

Hepatitis A Virus Epidemiology - Study findings on hepatitis A virus epidemiology are outlined in reports from G. Pontrelli and colleagues

HIV/AIDS - Data on HIV/AIDS reported by researchers at Columbia University

HIV/AIDS - Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors

HIV/AIDS - Research from G.J. Kotwal and colleagues has provided new data on HIV/AIDS

Immunization - Data from T.N. Mcneilly et al provide new insights into immunization

IMPAX Laboratories, Inc. - IMPAX Reports Positive Results in Phase III Trial with IPX056

Inhibitory Peptides - Studies from N.R. Silvaggi et al have provided new data on inhibitory peptides

Introgen Therapeutics, Inc. - Introgen Therapeutics Reports Second Quarter 2008 Financial Results and Recent Corporate Highlights

Iron Overload - Studies from J. Karnon and colleagues reveal new findings on iron overload

Jellyfish Squish - Testing by Marine Biologists Concludes That Jellyfish Squish Completely Eliminates Pain From Jellyfish Stings

Jellyfish Squish - Testing by Marine Biologists Concludes That Jellyfish Squish(TM) Completely Eliminates Pain From Jellyfish Stings

Kamada - The Israeli Ministry of Health Elects Kamada to be the Exclusive Developer and Manufacturer of Snakebite Antiserums in Israel

King Pharmaceuticals, Inc. - King Pharmaceuticals Reports Second-Quarter 2008 Financial Results

Legionnaire Disease - New findings in legionnaire disease described by P.Y. Yu and co-researchers

Leukemia Therapy - Study data from Brown University update knowledge of leukemia therapy

Life Sciences - Data on life sciences reported by S. Moussabadran and co-researchers

Life Sciences - Findings from National Institute of Health Science advance knowledge in life sciences

Life Sciences - Findings in life sciences reported from A. Kim and co-researchers

Life Sciences - New findings from S. Ormarsdottir and co-researchers in the area of life sciences described

Life Sciences - Reports outline life sciences research from Columbia University

Life Sciences - Research findings from Harvard University, Medical Department update understanding of life sciences

Life Sciences - Researchers from American University discuss findings in life sciences

Lymphoma - Craig W. Philips Takes Helm at CTI

Marketing and Licensing Agreements - Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN

Medgenics, Inc. - Medgenics Granted Approval to Commence Its Landmark Phase I/II Clinical Study of EPODURE to Treat Anaemia

Medtronic, Inc. - Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor and Cypher Drug-Eluting Stents

Menopause - Research from G.B. Mahady et al broadens understanding of menopause

Menstruation - Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding

Monoclonal Antibodies - Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody

Monoclonal Antibodies - Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs

Monsanto Company - Monsanto to Pursue Divestiture of POSILAC

Mumps - China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger

NewStar Fresh Foods - Fresh Cilantro Recall by NewStar Fresh Foods Proves Unnecessary

Noven Pharmaceuticals, Inc. - Noven Announces Final FDA Approval of Stavzor for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches

Organogenesis, Inc. - Organogenesis, Inc. Announces Apligraf Cell Therapy Reimbursed in Switzerland

Osteoporosis - VAI Finding Could Lead to Improved Osteoporosis Drug Design

Othera Pharmaceuticals, Inc. - Othera Files IND Application for OT-730 in Glaucoma

Plague - Studies from D.J. Salkeld and colleagues provide new data on plague

Pneumococcal Disease Vaccines - Studies from Health Protection Agency yield new data on pneumococcal disease vaccines

POZEN, Inc. - POZEN Receives Initial FDA Response To PA32540 SPA

QRxPharma Limited - FDA Accepts Streamlined Phase 3 Development Plan for Q8003IR 'Dual Opioid' Pain Therapy

QualSec - QualSec: the Future of Counterterrorism

Radiometer - New CO-oximetry Module for the ABL80 FLEX Blood Gas Analyzer

Refractive Surgery - New refractive surgery study findings have been reported by G.G. Quinto and co-researchers

Regenerative Medicine - Organogenesis, Inc. Announces Apligraf(R) Cell Therapy Reimbursed in Switzerland

RegeneRx Biopharmaceuticals, Inc. - RegeneRx Awarded Additional $136,000 from FDA Office of Orphan Products for Phase II Epidermolysis Bullosa Trial

Regulatory Actions - Findings in regulatory actions reported from Center for Devices and Radiological Health

Regulatory Actions - Research on regulatory actions reported by scientists at University of Washington

Regulatory Actions - SemBioSys announces second quarter 2008 financial and operational results

Roche - Roche's xCELLigence System Designed to Reduce Animal Testing in Pharmaceutical Development

sanofi-aventis - Multaq dronedarone Granted FDA Priority Review for Patients with Atrial Fibrillation

Sorin Group - Sorin Group Announces FDA Approval and First U.S. Implant of the World's Smallest Implantable Dual Chamber Pacemaker

St. Jude Medical, Inc. - St. Jude Medical Announces Japanese Approval of the Durata Defibrillation Lead

Stereotaxis, Inc. - Stereotaxis Reports Record Second Quarter Revenue

Syracuse University - Syracuse University scientists discover how some bacteria may steal iron from their human hosts

Targanta Therapeutics Corporation - Targanta Reports Second Quarter and Six-Month 2008 Financial Results

The Medicines Company - The Medicines Company's Cleviprex Receives FDA Approval

TriMix Laboratories Llc - TriMix Laboratories Announces New Partnership With American Pharmacy Solutions

University of Manchester - Study reveals cost of stabbings to Britain's health service

UT Southwestern Medical Center - STAR*D study leaders at UT Southwestern test two-drug approach to depression in new CO-MED trial

Vapotherm, Inc. - Vapotherm Precision Flow Receives FDA 510k Clearance

Venable Llp - Statement from Attorneys Representing Dr. Bruce Ivins During Anthrax Investigation

Vyteris, Inc. - Vyteris Announces Launch of Initiative to Pursue Joint Development Agreements in Pain Management

West Nile Virus - Research from Erasmus Medical Center, Department of Virology yields new findings on west nile virus

West Nile Virus - Research on west nile virus detailed by scientists at Blood Center

Women's Health - Study data from National Institute of Public Health and the Environment provide new insights into women's health



Return to Top of Page

-----------------------
PR Login